Loading market dashboard
Mereo BioPharma Group plc
MREOHealthcareNASDAQGB
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Mereo BioPharma Group plc · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $104.30M | $90.63M - $117.97M | $10.80M | $0.01 | 1 |
| Dec 2029 | $28.80M | $25.03M - $32.57M | $2.98M | -$0.06 | 2 |
| Dec 2028 | $48.24M | $41.92M - $54.56M | $5.00M | $0.117 | 3 |
| Dec 2027 | $27.12M | $22.71M - $31.53M | $2.81M | -$0.008 | 5 |
| Dec 2026 | $14.28M | $13.05M - $15.50M | $1.48M | -$0.012 | 4 |
| Dec 2025 | $6.27M | $5.45M - $7.09M | $649.1K | -$0.056 | 4 |
| Dec 2024 | $18.13M | $15.75M - $20.50M | $1.88M | -$0.061 | 4 |
| Dec 2023 | $1.00M | $869.0K - $1.13M | $103.6K | -$0.263 | 3 |
| Dec 2022 | $7.13M | $6.23M - $8.02M | $3.59M | -$0.079 | 1 |
| Dec 2021 | $24.86M | $21.73M - $27.98M | $12.52M | -$0.063 | 1 |